2014
DOI: 10.1007/s11160-014-9374-6
|View full text |Cite
|
Sign up to set email alerts
|

Sedative options for fish research: a brief review with new data on sedation of warm-, cool-, and coldwater fishes and recommendations for the drug approval process

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
31
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 29 publications
(33 citation statements)
references
References 26 publications
1
31
0
1
Order By: Relevance
“…Anesthetic drugs are often used to calm or immobilize fish for data or tissue collection procedures and can reduce some indications of secondary stress response and help minimize injuries to the fish and biologist (Ross and Ross 2008). There are, however, few anesthetic choices available for fish research, and the effects of anesthesia in many fish species are unknown (Bowker et al 2015). Tricaine methanesulfonate (MS-222) has been one of the most widely used anesthetics in fisheries research.…”
mentioning
confidence: 99%
“…Anesthetic drugs are often used to calm or immobilize fish for data or tissue collection procedures and can reduce some indications of secondary stress response and help minimize injuries to the fish and biologist (Ross and Ross 2008). There are, however, few anesthetic choices available for fish research, and the effects of anesthesia in many fish species are unknown (Bowker et al 2015). Tricaine methanesulfonate (MS-222) has been one of the most widely used anesthetics in fisheries research.…”
mentioning
confidence: 99%
“…In a study of representative coldwater, coolwater, and warmwater species of freshwater fish sedated with eugenol, MS‐222, or benzocaine, Bowker et al. () reported that the response of fish to chemical sedatives was primarily a function of sedative dose, water temperature, and, to a lesser extent, fish size and dissolved oxygen concentration but not taxonomic classification.…”
Section: Discussionmentioning
confidence: 99%
“…, , ; Bowker et al. ); however, as a precautionary measure to ensure the safety of the American food supply, the FDA requires that fish exposed to Tricaine‐S be held for 21 d (i.e., withdrawal period) prior to entering the human food chain via release into the aquatic environment or harvest from a production facility (FDA ). The withdrawal requirement constrains fisheries management and research activities because, for most field applications, holding fish for 21 d postsedation is impractical or even impossible.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The sedative mode of action for eugenol is associated with its ability to interfere with changes in membrane permeability necessary to conduct nervous stimuli. Considerable data have been generated to demonstrate that AQUI-S 20E effectively sedates freshwater fish (Trushenski et al 2012a(Trushenski et al , 2012bBowker et al 2015b) and marine fish to a "handleable" state (Trushenski et al 2012c;Bowker et al 2015aBowker et al , 2016, and AQUI-S 20E is expected to be the next sedative approved by FDA for use on fish in the United States. It is likely that some approved uses will not require a withdrawal period, allowing AQUI-S 20E to be used as a sedative for fish destined for immediate release.…”
mentioning
confidence: 99%